Hormone replacement therapy: Use in the Michigan Medicaid population during the 1980s

Thomas P. Gross; Steven C. Kaufman; Rita Schinnar; Carlene Baum; Brian L. Strom

Hormone replacement therapy: Use in the Michigan Medicaid population during the 1980s

Thomas P. Gross, Steven C. Kaufman, Rita Schinnar, Carlene Baum, Brian L. Strom

Research output: Contribution to journal › Article › peer-review

Abstract

Claims data from files of the Michigan Medicaid Information System were used to examine the use of hormone replacement therapy (HRT) among female Michigan Medicaid recipients during the 1980s and to compare this use to national estimates derived from the National Prescription Audit and the National Disease and Therapeutic Index. By 1989, 1 in 15 female Medicaid recipients aged 40 years and older, and nearly twice as many aged 50-59, were on HRT. Throughout the decade, unopposed estrogen therapy was most prevalent in whites and in those 40-59 years old, with usage decreasing with age. Combination therapy with progestins accounted for 28% of HRT by 1989, with several-fold increases in use noted in certain age groups and in both whites and blacks. Similarly, national data showed substantial increased numbers of prescriptions dispensed for noncontraceptive estrogens and progestins during the 1980s.

Original language	American English
Pages (from-to)	7-20
Number of pages	14
Journal	Journal of Pharmacoepidemiology
Volume	5
Issue number	2
State	Published - 1996
Externally published	Yes

ASJC Scopus subject areas

General Pharmacology, Toxicology and Pharmaceutics
Pharmacology (medical)

Cite this

@article{76f6b5c78bcd4227a833adae74ae879c,

title = "Hormone replacement therapy: Use in the Michigan Medicaid population during the 1980s",

abstract = "Claims data from files of the Michigan Medicaid Information System were used to examine the use of hormone replacement therapy (HRT) among female Michigan Medicaid recipients during the 1980s and to compare this use to national estimates derived from the National Prescription Audit and the National Disease and Therapeutic Index. By 1989, 1 in 15 female Medicaid recipients aged 40 years and older, and nearly twice as many aged 50-59, were on HRT. Throughout the decade, unopposed estrogen therapy was most prevalent in whites and in those 40-59 years old, with usage decreasing with age. Combination therapy with progestins accounted for 28% of HRT by 1989, with several-fold increases in use noted in certain age groups and in both whites and blacks. Similarly, national data showed substantial increased numbers of prescriptions dispensed for noncontraceptive estrogens and progestins during the 1980s.",

author = "Gross, {Thomas P.} and Kaufman, {Steven C.} and Rita Schinnar and Carlene Baum and Strom, {Brian L.}",

year = "1996",

language = "American English",

volume = "5",

pages = "7--20",

journal = "Journal of Pharmacoepidemiology",

issn = "0896-6966",

publisher = "John Wiley and Sons Inc.",

number = "2",

}

TY - JOUR

T1 - Hormone replacement therapy

T2 - Use in the Michigan Medicaid population during the 1980s

AU - Gross, Thomas P.

AU - Kaufman, Steven C.

AU - Schinnar, Rita

AU - Baum, Carlene

AU - Strom, Brian L.

PY - 1996

Y1 - 1996

N2 - Claims data from files of the Michigan Medicaid Information System were used to examine the use of hormone replacement therapy (HRT) among female Michigan Medicaid recipients during the 1980s and to compare this use to national estimates derived from the National Prescription Audit and the National Disease and Therapeutic Index. By 1989, 1 in 15 female Medicaid recipients aged 40 years and older, and nearly twice as many aged 50-59, were on HRT. Throughout the decade, unopposed estrogen therapy was most prevalent in whites and in those 40-59 years old, with usage decreasing with age. Combination therapy with progestins accounted for 28% of HRT by 1989, with several-fold increases in use noted in certain age groups and in both whites and blacks. Similarly, national data showed substantial increased numbers of prescriptions dispensed for noncontraceptive estrogens and progestins during the 1980s.

AB - Claims data from files of the Michigan Medicaid Information System were used to examine the use of hormone replacement therapy (HRT) among female Michigan Medicaid recipients during the 1980s and to compare this use to national estimates derived from the National Prescription Audit and the National Disease and Therapeutic Index. By 1989, 1 in 15 female Medicaid recipients aged 40 years and older, and nearly twice as many aged 50-59, were on HRT. Throughout the decade, unopposed estrogen therapy was most prevalent in whites and in those 40-59 years old, with usage decreasing with age. Combination therapy with progestins accounted for 28% of HRT by 1989, with several-fold increases in use noted in certain age groups and in both whites and blacks. Similarly, national data showed substantial increased numbers of prescriptions dispensed for noncontraceptive estrogens and progestins during the 1980s.

UR - http://www.scopus.com/inward/record.url?scp=0029779353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029779353&partnerID=8YFLogxK

M3 - Article

SN - 0896-6966

VL - 5

SP - 7

EP - 20

JO - Journal of Pharmacoepidemiology

JF - Journal of Pharmacoepidemiology

IS - 2

ER -

Hormone replacement therapy: Use in the Michigan Medicaid population during the 1980s

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this